INVIVO THERAPEUTICS

Codice
nviv
Risorse esterne
Opinione della community
Prezzo Variazione Volume
4.3 0 €
(0.00%)
108283
P/E Obiettivo ad 1anno
0 19.42 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 29
Sell : 4

Simone Bonzanini parcall ghed LucaMazzu91 Domenico23

Commenti


Notizie

Investors Attention Alert: InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) - Is stories

The stock as of last trading session moved 7.50% up from its 52 week low and was -58.49% behind its 52 week high. The stock's price switched up -5.73% 20-Days Simple Moving Average, dropped -3.03% from 50-Days Simple Moving Average and fell ...altro » Leggi

InVivo Therapeutics Holdings Corp. (NVIV) Plunges 5.05% on January 30 - Equities.com

InVivo Therapeutics Holdings Corp. (NVIV) had a rough trading day for Monday January 30 as shares tumbled 5.05%, or a loss of $-0.25 per share, to close at $4.70. After opening the day at $4.90, shares of InVivo Therapeutics Holdings Corp. traded as ... Leggi

Investing Focus: Indicators in View on Shares of InVivo Therapeutics Holdings Corp (NVIV) - Davidson Register

On the other side, a stock may be considered to be in a downtrend if trading below the moving average and sloping downward. Traders may be relying in part on technical stock analysis. InVivo Therapeutics Holdings Corp (NVIV) currently has a 14-day ...altro » Leggi

Momentum Targets on Watch For InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) Orion Energy Systems, Inc ... - Sherwood Daily

Momentum Targets on Watch For InVivo Therapeutics Holdings Corp. ... In taking a look at technical levels, shares are trading -13.98% away from the 50 day simple moving average and 14.14% away from the 200 day simple moving average. Based on a ... Leggi

InVivo Therapeutics to Present at 2017 BIO CEO & Investor Conference - Yahoo Finance

InVivo Therapeutics Holdings Corp. (NVIV) today announced that Mark Perrin, Chief Executive Officer and Chairman, will present at the 2017 BIO CEO & Investor Conference on Monday, February 13, 2017 at 11:30 A.M. Eastern Time at the Waldorf Astoria in ...altro » Leggi

Trading Options During Earnings in InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) - CML News

We're going to examine buying and selling out of the money strangles in InVivo Therapeutics Holdings Corp. and find out once and for all what the winning trades have been during earnings releases. With the right tool kit it's easy to find an explicit ...altro » Leggi

Trading Covered Calls: InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) : Using Covered Calls During Earnings - CML News

As we look at InVivo Therapeutics Holdings Corp. we note that a covered call is one of the most common implementations of an option strategy, but the analysis completed when employing the covered call often times lacks the necessary rigor especially ...altro » Leggi

Trading Covered Calls: InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) : Covered Calls, Earnings and Intelligence - CML News

As we look at InVivo Therapeutics Holdings Corp. we note that a covered call is one of the most common implementations of an option strategy, but the analysis completed when employing the covered call often times lacks the necessary rigor especially ...altro » Leggi

Option Trading: InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) Winning Long Put Spreads Can Outperform ... - CML News

There is a lot less 'luck' involved in successful option trading than many people have come to understand. We can get specific with long put spreads on NVIV in this dossier. Let's look at a three-year back-test of a long put spread strategy and use the ... Leggi

What analyst said about Price Target Levels? InVivo Therapeutics Holdings Corp.'s (NVIV) - Is stories

InVivo Therapeutics Holdings Corp.'s (NVIV) witnessed a gain of 7.95% in recent trading period with closing price of $4.75. The company's last traded volume of 0.14 million shares as compared to it's an average volume of 0.2 million shares. In the ...altro » Leggi